Target intelligence / Profile preview

General transcription factor IIi pseudogene 3 (GTF2IP3)

Target: GTF2IP3
Molecular classification: Other (Pseudogene)

Overview

General transcription factor IIi pseudogene 3 (GTF2IP3) is classified as a pseudogene in the human genome. This DNA segment structurally resembles a protein-coding gene but has accumulated mutations that prevent it from directing the synthesis of a functional protein. Pseudogenes like GTF2IP3 are not active in cellular processes, do not have defined molecular function, and are not considered therapeutic targets. Their study is primarily relevant for understanding genomic architecture and evolutionary history, but GTF2IP3 does not have known clinical or molecular utility.

Other names: General transcription factor II, i pseudogeneGTF2IP3

Beyond the preview

Go deeper on General transcription factor IIi pseudogene 3 (GTF2IP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on General transcription factor IIi pseudogene 3 (GTF2IP3).

Explore the full profile